Advertisement

Advertisement

Expert���s Corner

Advertisement

Advertisement



Feb
22
Today In Oncology
Benefit of Annual Screening in Women Aged 35–39 With a Family History of Breast Cancer
Cutaneous T-Cell Lymphoma: Can Genetic Polymorphisms Help Select Patients for Treatment With Bexarotene?
Addition of First-Line Ramucirumab to Cisplatin and Fluoropyrimidine in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
DYNAMO: Duvelisib in Refractory Indolent Non-Hodgkin Lymphoma
Hospitalizations in Patients With Prostate Cancer on Medicare
View More 
;
Advertisement
Most Read Stories
FDA Pipeline: Priority Reviews in Renal Cell Carcinoma and Head and Neck Cancer
2019 GU Cancers Symposium: JAVELIN Renal 101: Avelumab Plus Axitinib vs Sunitinib for Advanced Kidney Cancer
2019 GU Cancers Symposium: KEYNOTE-426: Pembrolizumab Plus Axitinib vs Sunitinib in Advanced Renal Cell Carcinoma
CMS Proposes Medicare Coverage With Evidence Development for CAR T-Cell Therapy
Meta-analysis of Outcomes With Dose-Intense Adjuvant Chemotherapy in Early Breast Cancer
View More 
Most Viewed Videos
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
Brian I. Rini, MD, and Thomas Powles, MD, PhD, on Renal Cell Carcinoma: Results From the KEYNOTE-426 Trial on Pembrolizumab Plus Axitinib vs Sunitinib
Zaida Morante, MD, on Triple-Negative Breast Cancer: Delaying Adjuvant Chemotherapy
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
View More 
© 2019 HSP News Service, L.L.C.